体重对狗中普得尼索隆的药理动力学的影响
Bonnie L Purcell1,2, Andrew P Woodward3,4, Michael G Leeming5
1Department of Veterinary Clinical Sciences, University of Melbourne, Werribee, Victoria, Australia.
PloS one
|July 8, 2025
概括
狗中普雷尼索隆的药理动力学与体重有非线性关系. 目前的剂量模型对于临床使用来说过于不准确,这表明需要对犬类药物剂量的进一步研究.
科学领域:
- 兽医药理学 兽医药理学
- 药理动力学 药理动力学
- 狗医疗 狗医疗 狗医疗
背景情况:
- 较大的狗可能面临更高的普雷迪尼索隆副作用风险.
- 关于体重如何影响狗狗中的普雷迪尼索隆药理动力学的研究有限.
研究的目的:
- 为了研究狗的普得尼索隆剂量,体重,身体表面积 (BSA) 和血普得尼索隆曲线下的面积 (AUC) 之间的关系.
- 在客户拥有的狗中开发普雷迪尼索隆的药理动力学模型.
主要方法:
- 在25只客户拥有的狗身上进行了一项观察性群体药理动力学研究.
- 用液体染色学双重质谱法量化了血中的普雷迪尼索隆度.
- 贝叶斯非线性回归模型分析了8小时AUC,体重和普雷尼索隆剂量之间的关系.
主要成果:
- 一个全米缩放模型表明,体重和普得尼索隆AUC之间存在非线性关系.
- 该模型建议BSA和体重之间的中间剂量策略,但证据相对较弱.
- 缩放指数为0.83 (90% CrI:0.60-1.06). 这是一个很好的方法.
结论:
- 证据支持在狗中普得尼索隆的药理动力学和体重之间存在非线性关系.
- 目前的药理动力学模型太不精确,无法直接确定临床剂量.
- 基于体重的剂量策略的进一步细化是合理的.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
305
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
305
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Nonlinear Pharmacokinetics: Overview
568
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
568
Hepatic Drug Excretion: Influencing Factors
231
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
231
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
133
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
133
Renal Failure: Dose Adjustments
164
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
164


